FDA

FDA pushing to eliminate most prescriptions; make majority of drugs over-the-counter

Saturday, August 04, 2012 by: Daniel C. Mizzi
Tags: prescription drugs, FDA, over the counter

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
10 other companies that use the same Subway yoga mat chemical in their buns
High-dose vitamin C injections shown to annihilate cancer
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Battle for humanity nearly lost: global food supply deliberately engineered to end life, not nourish it
Russia taking McDonald's to court, threatens countrywide shutdown
Diet soda, aspartame linked to premature deaths in women
Cannabis kicks Lyme disease to the curb
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Harvard research links fluoridated water to ADHD, mental disorders
Delicious
(NaturalNews) The FDA is considering a new prescription program also referred to as the "New Paradigm" that would enable certain prescription drugs to be available without a prescription if they met certain criteria that ensured "conditions of safe use." The program would involve a variety of medications that treat so-called "common conditions" (i.e. hypertension, diabetes, elevated cholesterol, migraine headaches, asthma, flu, allergies, smoking cessation etc.) The FDA's apparent rationale behind this proposal is based on evidence from the National Journal that shows that people in the U.S. have poor medication adherence due to a variety of factors (i.e. costs, time, need for multiple physician visits, lack of a prescription drug plan and so on) that ultimately hamper the prescription and medication renewal processes. In addition, the FDA believes that these factors dissuade people from taking potentially lifesaving medications which further contributes to the under-treatment of common medical conditions.

Suggested Methods to Implement the New Prescription Paradigm

Although the FDA has not yet decided how to expand access of certain prescription medications, one key element of their proposal surrounds a pharmacist-driven patient care program that would likely involve patient counseling, patient monitoring, drug interaction prevention and simple diagnostic testing. Another element of the proposal, suggested by the FDA, may involve having a physician prepare the initial prescription for the medication with subsequent access to the medication without a prescription if "conditions of safe use" are met. Lastly, the FDA believes various technologies like pharmacy-based kiosks or internet based questionnaires may help support their proposal by helping patients properly self-diagnose and select the appropriate medication(s) for their condition(s).

What Supporters and Opponents of the "New Paradigm" are Saying

Supporters of this initiative (i.e. American Pharmacists Association) believe the FDA proposal would help improve access to prescription medications for the public (especially the uninsured), reduce healthcare expenditures, increase access to health screenings, reduce unnecessary doctor office visits, reduce the burden on our existing healthcare system, and allow physicians to have more time to focus on more critically ill patients.

On the other hand, opponents of this initiative (i.e. American Academy of Family Physicians and the American Medical Association) believe the plan may not reduce the overall costs of healthcare since there are too many unknowns relating to the patient's level of care, possible lack of monitoring and potential health risks that could ensue without physician involvement. Furthermore, opponents of this proposal believe it will merely transfer medication costs from insurance companies and third party payers back to the consumer.

Drug Companies Likely to Benefit the Most From The "New Paradigm"

Based on the FDA's "New Paradigm" proposal, it would seem this initiative would enable more complex therapies that have been rejected in the past (i.e. statin drugs which no longer have patent exclusivity or are nearing patent expiration) to have a route for OTC (over-the-counter) sales. Thus, if the FDA's proposal is approved, the pipeline of potential drug candidates to enter the very profitable OTC market may expand greatly regardless of the consequences this proposal may have on our integrated healthcare system.

Sources for this article include:
http://www.ncbi.nlm.nih.gov/pubmed/15519288?dopt=Abstract
http://www.ncbi.nlm.nih.gov/pubmed/18471457
http://www.ncbi.nlm.nih.gov/pubmed/16516588
http://www.ncbi.nlm.nih.gov/pubmed/17696570
http://drugstorenews.com
http://www.pharmacistactivist.com/2012/March_2012.shtml
http://abcnews.go.com
http://www.ibtimes.com/articles/193730/20110806/otc-statins.htm
http://online.wsj.com
http://www.drugstorenews.com
http://www.usatoday.com
http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm297128.htm
http://www.ozpharmagroup.com
http://www.pharmacytimes.com
http://www.amcp.org/data/jmcp/Review-499-508.pdf
http://www.regulations.gov/#!documentDetail;D=FDA-2012-N-0171-0001
http://www.advisory.com/Daily-Briefing/2012/03/02/New-Rx-paradigm
http://www.eyeonfda.com

About the author:
Daniel C. Mizzi, R.Ph., Pharm.D.
Registered clinical pharmacist/staff writer with a sincere interest in natural/integrative medicine and author of the blog-site "The OTC Guide to Common Medical Conditions" http://otcguide.blogspot.com/.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.